Olin Biology (688319.SH) announced its semi-annual report for 2024, with operating income of 0.226 billion yuan, a year-on-year decrease of 2.97%; net income attributable to shareholders of listed companies was -27.947 million yuan.
欧林生物(688319.SH)：上半年净亏损2794.7万元
Olin Bio (688319.SH): net loss of 27.947 million yuan in the first half of the year.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.